These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30773699)

  • 1. Hyaluronic Acid-Based Activatable Nanomaterials for Stimuli-Responsive Imaging and Therapeutics: Beyond CD44-Mediated Drug Delivery.
    Choi KY; Han HS; Lee ES; Shin JM; Almquist BD; Lee DS; Park JH
    Adv Mater; 2019 Aug; 31(34):e1803549. PubMed ID: 30773699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
    Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
    Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.
    Choi KY; Saravanakumar G; Park JH; Park K
    Colloids Surf B Biointerfaces; 2012 Nov; 99():82-94. PubMed ID: 22079699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Responsive "Turn-On" Nanocarriers for Efficient Site-Specific Gene Delivery In Vitro and In Vivo.
    He Y; Zhou J; Ma S; Nie Y; Yue D; Jiang Q; Wali AR; Tang JZ; Gu Z
    Adv Healthc Mater; 2016 Nov; 5(21):2799-2812. PubMed ID: 27717282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bimodal tumor-targeting from microenvironment responsive hyaluronan layer-by-layer (LbL) nanoparticles.
    Dreaden EC; Morton SW; Shopsowitz KE; Choi JH; Deng ZJ; Cho NJ; Hammond PT
    ACS Nano; 2014 Aug; 8(8):8374-82. PubMed ID: 25100313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44-Targeted Hyaluronic Acid-Coated Redox-Responsive Hyperbranched Poly(amido amine)/Plasmid DNA Ternary Nanoassemblies for Efficient Gene Delivery.
    Gu J; Chen X; Ren X; Zhang X; Fang X; Sha X
    Bioconjug Chem; 2016 Jul; 27(7):1723-36. PubMed ID: 27311558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
    Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
    Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel dual ROS-sensitive and CD44 receptor targeting nanomicelles based on oligomeric hyaluronic acid for the efficient therapy of atherosclerosis.
    Hou X; Lin H; Zhou X; Cheng Z; Li Y; Liu X; Zhao F; Zhu Y; Zhang P; Chen D
    Carbohydr Polym; 2020 Mar; 232():115787. PubMed ID: 31952595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of hyaluronidase as an anticancer agent inhibiting CD44.
    Shakouri A; Parvan R; Adljouy N; Abdolalizadeh J
    Biomed Chromatogr; 2020 Jan; 34(1):e4709. PubMed ID: 31630417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 Targeted Lipid Nanoparticles for MicroRNA Therapy.
    Hayward SL; Kidambi S
    Methods Mol Biol; 2018; 1831():95-109. PubMed ID: 30051427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical hyaluronidase decreases hyaluronic acid and CD44 in human skin and in reconstituted human epidermis: evidence that hyaluronidase can permeate the stratum corneum.
    Laugier JP; Shuster S; Rosdy M; Csóka AB; Stern R; Maibach HI
    Br J Dermatol; 2000 Feb; 142(2):226-33. PubMed ID: 10730753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation.
    Seok HY; Sanoj Rejinold N; Lekshmi KM; Cherukula K; Park IK; Kim YC
    J Control Release; 2018 Jun; 280():20-30. PubMed ID: 29723613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indocyanine green encapsulated nanogels for hyaluronidase activatable and selective near infrared imaging of tumors and lymph nodes.
    Mok H; Jeong H; Kim SJ; Chung BH
    Chem Commun (Camb); 2012 Sep; 48(69):8628-30. PubMed ID: 22745939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy.
    Edelman R; Assaraf YG; Levitzky I; Shahar T; Livney YD
    Oncotarget; 2017 Apr; 8(15):24337-24353. PubMed ID: 28212584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid for anticancer drug and nucleic acid delivery.
    Dosio F; Arpicco S; Stella B; Fattal E
    Adv Drug Deliv Rev; 2016 Feb; 97():204-36. PubMed ID: 26592477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
    Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
    Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
    Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
    Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.